Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator

Abstract Peroxisome proliferator-activated receptor γ (PPARγ) remains a critical target for antidiabetic drug development due to its role in glucose and lipid metabolism. However, the adverse effects associated with full agonists of the thiazolidinedione (TZD) class, such as weight gain and hepatoto...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Ayman M. Ibrahim, Mai E. Shoman, Radwa Taher Mohie el-dien, Entesar Ali Saber, Mahmoud Abdelnaser, Sherif A. Maher, Alaa M. Hayallah, Mahmoud Abdul-Aziz El-Rehany, Gamal El-Din A. Abuo-Rahma
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-06-01
Subjects:	Quinoline Thiazolidinedione PPARγ Antidiabetic SPPARMs
Online Access:	https://doi.org/10.1038/s41598-025-03387-9